Skip to site menu Skip to page content
Logo Image
In Brief
Spotlight

Targeted therapies to join chemo as oncology treatment backbone

Experts agree that combination approaches, which may or may not include chemotherapy, will drive improved patient outcomes in oncology.

Latest news

Sanofi bets on Sino Biopharm’s transplant drug in $1.5bn licensing deal

By blocking the JAK and ROCK pathways, rovadicitinib offers a differentiated mechanism of action to best-selling, single-target GVHD drugs like Jakavi and Imbruvica.

Affinia receives FDA fast track designation for AFTX-201

The designation aims to accelerate medicines that address unmet medical needs in serious conditions.

CordenPharma leases space at Flatiron Park for peptides development

CordenPharma Colorado will occupy the 5505 Central building under a 15-year lease.

Europe’s pharma trade with the US remains critical despite tariff turmoil

New drugs and lucrative markets in the US remain crucial to Europe’s pharma sector, as governments approach closer trade with Asia.

Pharma rings the changes as CEO shake-up continues

While some chief executives have left for personal reasons, others have been ousted amid poor company performance.